Skip to main content
NCBI home page
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1997 Jun;35(6):1304–1310. doi: 10.1128/jcm.35.6.1304-1310.1997

PCR detection of human papillomavirus: comparison between MY09/MY11 and GP5+/GP6+ primer systems.

W Qu 1, G Jiang 1, Y Cruz 1, C J Chang 1, G Y Ho 1, R S Klein 1, R D Burk 1
PMCID: PMC229739  PMID: 9163434

Abstract

Human papillomavirus (HPV) is an etiologic agent of cervical cancer and is the most common sexually transmitted disease in women. PCR amplification of HPV genomes is the most sensitive method for the detection of cervicovaginal HPV. We have compared the two most commonly used PCR primer sets, MY09/MY11 (MY-PCR) and GP5+/GP6+ (GP+-PCR), for the detection of HPV DNA in cervicovaginal lavage samples from 208 women. Oligonucleotide probes for 39 different HPV types were used. Both primer sets amplified a wide spectrum of HPV genotypes and detected similar overall prevalences of 45% (94 of 208) and 43% (89 of 208), respectively. The MY-PCR system detected 27 of 30 (90%) samples with multiple HPV types, whereas the GP+-PCR system detected 14 of 30 (47%) samples with multiple HPV types. Differences in the detection of HPV types 35, 53, and 61 were noted between the two primer systems. Serial dilution of plasmid templates indicated a 3-log decrease in the amplification of HPV type 35 by MY-PCR and HPV types 53 and 61 by GP+-PCR. These results indicate that although the MY-PCR and GP+-PCR identified nearly equivalent prevalences of HPV in a set of clinical samples, differences in the detection of specific types and infections with multiple types were found. Differences in the sensitivities and characteristics of the PCR systems for the detection of HPV within clinical samples should be considered when comparing data between studies and/or in designing new studies or clinical trials.

Full Text

The Full Text of this article is available as a PDF (210.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baay M. F., Quint W. G., Koudstaal J., Hollema H., Duk J. M., Burger M. P., Stolz E., Herbrink P. Comprehensive study of several general and type-specific primer pairs for detection of human papillomavirus DNA by PCR in paraffin-embedded cervical carcinomas. J Clin Microbiol. 1996 Mar;34(3):745–747. doi: 10.1128/jcm.34.3.745-747.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Bauer H. M., Hildesheim A., Schiffman M. H., Glass A. G., Rush B. B., Scott D. R., Cadell D. M., Kurman R. J., Manos M. M. Determinants of genital human papillomavirus infection in low-risk women in Portland, Oregon. Sex Transm Dis. 1993 Sep-Oct;20(5):274–278. doi: 10.1097/00007435-199309000-00007. [DOI] [PubMed] [Google Scholar]
  3. Bauer H. M., Ting Y., Greer C. E., Chambers J. C., Tashiro C. J., Chimera J., Reingold A., Manos M. M. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA. 1991 Jan 23;265(4):472–477. [PubMed] [Google Scholar]
  4. Bosch F. X., Manos M. M., Muñoz N., Sherman M., Jansen A. M., Peto J., Schiffman M. H., Moreno V., Kurman R., Shah K. V. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst. 1995 Jun 7;87(11):796–802. doi: 10.1093/jnci/87.11.796. [DOI] [PubMed] [Google Scholar]
  5. Burk R. D., Ho G. Y., Beardsley L., Lempa M., Peters M., Bierman R. Sexual behavior and partner characteristics are the predominant risk factors for genital human papillomavirus infection in young women. J Infect Dis. 1996 Oct;174(4):679–689. doi: 10.1093/infdis/174.4.679. [DOI] [PubMed] [Google Scholar]
  6. Delius H., Hofmann B. Primer-directed sequencing of human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:13–31. doi: 10.1007/978-3-642-78487-3_2. [DOI] [PubMed] [Google Scholar]
  7. Eluf-Neto J., Booth M., Muñoz N., Bosch F. X., Meijer C. J., Walboomers J. M. Human papillomavirus and invasive cervical cancer in Brazil. Br J Cancer. 1994 Jan;69(1):114–119. doi: 10.1038/bjc.1994.18. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Franco E. L. Measurement errors in epidemiological studies of human papillomavirus and cervical cancer. IARC Sci Publ. 1992;(119):181–197. [PubMed] [Google Scholar]
  9. Gallahan D., Müller M., Schneider A., Delius H., Kahn T., de Villiers E. M., Gissmann L. Human papillomavirus type 53. J Virol. 1989 Nov;63(11):4911–4912. doi: 10.1128/jvi.63.11.4911-4912.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Guerrero E., Daniel R. W., Bosch F. X., Castellsagué X., Muñoz N., Gili M., Viladiu P., Navarro C., Zubiri M. L., Ascunce N. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J Clin Microbiol. 1992 Nov;30(11):2951–2959. doi: 10.1128/jcm.30.11.2951-2959.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Hildesheim A., Gravitt P., Schiffman M. H., Kurman R. J., Barnes W., Jones S., Tchabo J. G., Brinton L. A., Copeland C., Epp J. Determinants of genital human papillomavirus infection in low-income women in Washington, D.C. Sex Transm Dis. 1993 Sep-Oct;20(5):279–285. doi: 10.1097/00007435-199309000-00008. [DOI] [PubMed] [Google Scholar]
  12. Hildesheim A., Schiffman M. H., Gravitt P. E., Glass A. G., Greer C. E., Zhang T., Scott D. R., Rush B. B., Lawler P., Sherman M. E. Persistence of type-specific human papillomavirus infection among cytologically normal women. J Infect Dis. 1994 Feb;169(2):235–240. doi: 10.1093/infdis/169.2.235. [DOI] [PubMed] [Google Scholar]
  13. Ho G. Y., Burk R. D., Fleming I., Klein R. S. Risk of genital human papillomavirus infection in women with human immunodeficiency virus-induced immunosuppression. Int J Cancer. 1994 Mar 15;56(6):788–792. doi: 10.1002/ijc.2910560605. [DOI] [PubMed] [Google Scholar]
  14. Ho G. Y., Burk R. D., Klein S., Kadish A. S., Chang C. J., Palan P., Basu J., Tachezy R., Lewis R., Romney S. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst. 1995 Sep 20;87(18):1365–1371. doi: 10.1093/jnci/87.18.1365. [DOI] [PubMed] [Google Scholar]
  15. Hsing A. W., Burk R. D., Liaw K. L., Chen C. J., Zhang T., Schiffman M., Greer C. E., You S. L., Hsieh C. Y., Huang T. W. Interlaboratory agreement in a polymerase chain reaction-based human papillomavirus DNA assay. Cancer Epidemiol Biomarkers Prev. 1996 Jun;5(6):483–484. [PubMed] [Google Scholar]
  16. Jacobs M. V., de Roda Husman A. M., van den Brule A. J., Snijders P. J., Meijer C. J., Walboomers J. M. Group-specific differentiation between high- and low-risk human papillomavirus genotypes by general primer-mediated PCR and two cocktails of oligonucleotide probes. J Clin Microbiol. 1995 Apr;33(4):901–905. doi: 10.1128/jcm.33.4.901-905.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Jiang G., Qu W., Ruan H., Burk R. D. Elimination of false-positive signals in enhanced chemiluminescence (ECL) detection of amplified HPV DNA from clinical samples. Biotechniques. 1995 Oct;19(4):566–568. [PubMed] [Google Scholar]
  18. Karlsen F., Kalantari M., Jenkins A., Pettersen E., Kristensen G., Holm R., Johansson B., Hagmar B. Use of multiple PCR primer sets for optimal detection of human papillomavirus. J Clin Microbiol. 1996 Sep;34(9):2095–2100. doi: 10.1128/jcm.34.9.2095-2100.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Klein R. S., Ho G. Y., Vermund S. H., Fleming I., Burk R. D. Risk factors for squamous intraepithelial lesions on Pap smear in women at risk for human immunodeficiency virus infection. J Infect Dis. 1994 Dec;170(6):1404–1409. doi: 10.1093/infdis/170.6.1404. [DOI] [PubMed] [Google Scholar]
  20. Kuypers J. M., Critchlow C. W., Gravitt P. E., Vernon D. A., Sayer J. B., Manos M. M., Kiviat N. B. Comparison of dot filter hybridization, Southern transfer hybridization, and polymerase chain reaction amplification for diagnosis of anal human papillomavirus infection. J Clin Microbiol. 1993 Apr;31(4):1003–1006. doi: 10.1128/jcm.31.4.1003-1006.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Ley C., Bauer H. M., Reingold A., Schiffman M. H., Chambers J. C., Tashiro C. J., Manos M. M. Determinants of genital human papillomavirus infection in young women. J Natl Cancer Inst. 1991 Jul 17;83(14):997–1003. doi: 10.1093/jnci/83.14.997. [DOI] [PubMed] [Google Scholar]
  22. Liaw K. L., Hsing A. W., Chen C. J., Schiffman M. H., Zhang T. Y., Hsieh C. Y., Greer C. E., You S. L., Huang T. W., Wu T. C. Human papillomavirus and cervical neoplasia: a case-control study in Taiwan. Int J Cancer. 1995 Sep 4;62(5):565–571. doi: 10.1002/ijc.2910620513. [DOI] [PubMed] [Google Scholar]
  23. Melkert P. W., Hopman E., van den Brule A. J., Risse E. K., van Diest P. J., Bleker O. P., Helmerhorst T., Schipper M. E., Meijer C. J., Walboomers J. M. Prevalence of HPV in cytomorphologically normal cervical smears, as determined by the polymerase chain reaction, is age-dependent. Int J Cancer. 1993 Apr 1;53(6):919–923. doi: 10.1002/ijc.2910530609. [DOI] [PubMed] [Google Scholar]
  24. Morris B. J., Rose B. R., Flanagan J. L., McKinnon K. J., Loo C. Y., Thompson C. H., Flampoulidou M., Ford R. M., Hunter J. C., Nightingale B. N. Automated polymerase chain reaction for papillomavirus screening of cervicovaginal lavages: comparison with dot-blot hybridization in a sexually transmitted diseases clinic population. J Med Virol. 1990 Sep;32(1):22–30. doi: 10.1002/jmv.1890320105. [DOI] [PubMed] [Google Scholar]
  25. Morrison E. A., Ho G. Y., Vermund S. H., Goldberg G. L., Kadish A. S., Kelley K. F., Burk R. D. Human papillomavirus infection and other risk factors for cervical neoplasia: a case-control study. Int J Cancer. 1991 Aug 19;49(1):6–13. doi: 10.1002/ijc.2910490103. [DOI] [PubMed] [Google Scholar]
  26. Remmink A. J., Walboomers J. M., Helmerhorst T. J., Voorhorst F. J., Rozendaal L., Risse E. K., Meijer C. J., Kenemans P. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int J Cancer. 1995 May 4;61(3):306–311. doi: 10.1002/ijc.2910610305. [DOI] [PubMed] [Google Scholar]
  27. Schiffman M. H., Bauer H. M., Hoover R. N., Glass A. G., Cadell D. M., Rush B. B., Scott D. R., Sherman M. E., Kurman R. J., Wacholder S. Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia. J Natl Cancer Inst. 1993 Jun 16;85(12):958–964. doi: 10.1093/jnci/85.12.958. [DOI] [PubMed] [Google Scholar]
  28. Schiffman M. H., Bauer H. M., Lorincz A. T., Manos M. M., Byrne J. C., Glass A. G., Cadell D. M., Howley P. M. Comparison of Southern blot hybridization and polymerase chain reaction methods for the detection of human papillomavirus DNA. J Clin Microbiol. 1991 Mar;29(3):573–577. doi: 10.1128/jcm.29.3.573-577.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Schiffman M. H., Schatzkin A. Test reliability is critically important to molecular epidemiology: an example from studies of human papillomavirus infection and cervical neoplasia. Cancer Res. 1994 Apr 1;54(7 Suppl):1944s–1947s. [PubMed] [Google Scholar]
  30. Smits H. L., Bollen L. J., Tjong-A-Hung S. P., Vonk J., Van Der Velden J., Ten Kate F. J., Kaan J. A., Mol B. W., Ter Schegget J. Intermethod variation in detection of human papillomavirus DNA in cervical smears. J Clin Microbiol. 1995 Oct;33(10):2631–2636. doi: 10.1128/jcm.33.10.2631-2636.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Snijders P. J., van den Brule A. J., Schrijnemakers H. F., Snow G., Meijer C. J., Walboomers J. M. The use of general primers in the polymerase chain reaction permits the detection of a broad spectrum of human papillomavirus genotypes. J Gen Virol. 1990 Jan;71(Pt 1):173–181. doi: 10.1099/0022-1317-71-1-173. [DOI] [PubMed] [Google Scholar]
  32. Stewart A. C., Eriksson A. M., Manos M. M., Muñoz N., Bosch F. X., Peto J., Wheeler C. M. Intratype variation in 12 human papillomavirus types: a worldwide perspective. J Virol. 1996 May;70(5):3127–3136. doi: 10.1128/jvi.70.5.3127-3136.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Tachezy R., Van Ranst M. A., Cruz Y., Burk R. D. Analysis of short novel human papillomavirus sequences. Biochem Biophys Res Commun. 1994 Oct 28;204(2):820–827. doi: 10.1006/bbrc.1994.2533. [DOI] [PubMed] [Google Scholar]
  34. Tucker R. A., Johnson P. R., Reeves W. C., Icenogle J. P. Using the polymerase chain reaction to genotype human papillomavirus DNAs in samples containing multiple HPVs may produce inaccurate results. J Virol Methods. 1993 Aug;43(3):321–333. doi: 10.1016/0166-0934(93)90150-p. [DOI] [PubMed] [Google Scholar]
  35. Wan C. Y., Wilkins T. A. Spermidine facilitates PCR amplification of target DNA. PCR Methods Appl. 1993 Dec;3(3):208–210. doi: 10.1101/gr.3.3.208. [DOI] [PubMed] [Google Scholar]
  36. Ward P., Parry G. N., Yule R., Coleman D. V., Malcolm A. D. Comparison between the polymerase chain reaction and slot blot hybridization for the detection of HPV sequences in cervical scrapes. Cytopathology. 1990;1(1):19–23. doi: 10.1111/j.1365-2303.1990.tb00322.x. [DOI] [PubMed] [Google Scholar]
  37. Wheeler C. M., Parmenter C. A., Hunt W. C., Becker T. M., Greer C. E., Hildesheim A., Manos M. M. Determinants of genital human papillomavirus infection among cytologically normal women attending the University of New Mexico student health center. Sex Transm Dis. 1993 Sep-Oct;20(5):286–289. doi: 10.1097/00007435-199309000-00009. [DOI] [PubMed] [Google Scholar]
  38. al-Bekairi A. M., Qureshi S., Chaudhry M. A., Shah A. H. Uric acid as an inhibitor of cyclophosphamide-induced micronuclei in mice. Mutat Res. 1991 Feb;262(2):115–118. doi: 10.1016/0165-7992(91)90116-l. [DOI] [PubMed] [Google Scholar]
  39. de Roda Husman A. M., Walboomers J. M., Hopman E., Bleker O. P., Helmerhorst T. M., Rozendaal L., Voorhorst F. J., Meijer C. J. HPV prevalence in cytomorphologically normal cervical scrapes of pregnant women as determined by PCR: the age-related pattern. J Med Virol. 1995 Jun;46(2):97–102. doi: 10.1002/jmv.1890460203. [DOI] [PubMed] [Google Scholar]
  40. de Roda Husman A. M., Walboomers J. M., Meijer C. J., Risse E. K., Schipper M. E., Helmerhorst T. M., Bleker O. P., Delius H., van den Brule A. J., Snijders P. J. Analysis of cytomorphologically abnormal cervical scrapes for the presence of 27 mucosotropic human papillomavirus genotypes, using polymerase chain reaction. Int J Cancer. 1994 Mar 15;56(6):802–806. doi: 10.1002/ijc.2910560607. [DOI] [PubMed] [Google Scholar]
  41. de Roda Husman A. M., Walboomers J. M., van den Brule A. J., Meijer C. J., Snijders P. J. The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR. J Gen Virol. 1995 Apr;76(Pt 4):1057–1062. doi: 10.1099/0022-1317-76-4-1057. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES